Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a Phase 2 single-blind, randomized, multicenter study to compare the efficacy and safety of a single dose of TNX-1300 to placebo with usual care in patients with acute cocaine intoxication within the emergency department setting.
Epistemonikos ID: 42b4aa83fe961e9c87e85d340c01b67314e0ea3c
First added on: May 15, 2024